Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia von Byrd, John C., Kipps, Thomas J., Flinn, Ian W., Castro, Januaro, Lin, Thomas S., Wierda, William, Heerema, Nyla, Woodworth, James, Hughes, Steve, Tangri, Shabnam, Harris, Sarah, Wynne, Dee, Molina, Arturo, Leigh, Bryan, O'Brien, Susan

Volltext

Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia von BYRD, John C, O'BRIEN, Susan, MOLINA, Arturo, LEIGH, Bryan, HARRIS, Sarah, FLINN, Lan W, KIPPS, Thomas J, WEISS, Mark, KANTI RAI, LIN, Thomas S, WOODWORTH, James, WYNNE, Dee, REID, Jennifer

Volltext

Systemic lnterleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed b-cell lymphomatreated... von BERDEJA, Jesus G, HESS, Allan, LUCAS, David M, O'DONNELL, Paul, AMBINDER, Richard F, DIEHL, Louis F, CARTER-BROOKINS, Denise, NEWTON, Susan, FLINN, Lan W

Volltext

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma: Current and ongoing clinical development of immunotherapy in B-cell... von GORDON, Leo I, WITZIG, Thomas E, OLEJNIK, Teresa, WHITE, Christine A, GRILLO-LOPEZ, Antonio J, WISEMAN, Greg A, FLINN, Lan W, SPIES, Stewart S, SILVERMAN, Daniel H, EMMANUOLIDES, Christos, CRIPE, Larry, SALEH, Mansoor, CZUCZMAN, Myron S

Volltext

Rituximab using athrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity von BYRD, John C, MURPHY, Timothy, GRILLO-LOPEZ, Antonio J, ROSENBERG, Jay, KUNKEL, Lori, FLINN, Lan W, HOWARD, Robin S, LUCAS, Margaret S, GOODRICH, Amy, PARK, Kathy, PEARSON, Michael, WASELENKO, Jamie K, LING, Geoffrey, GREVER, Michael R

Volltext

YTB323 (Rapcabtagene Autoleucel) Demonstrates Durable Efficacy and a Manageable Safety Profile in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Phase I Study Upd... von Barba, Pere, Kwon, Mi, Briones, Javier, Jaeger, Ulrich, Bachy, Emmanuel, Blaise, Didier, Boissel, Nicolas, Kato, Koji, Shah, Nirav N., Frigault, Matthew, Riedell, Peter A., Shune, Leyla O., Teshima, Takanori, Ciceri, Fabio, Pearson, David, Orlando, Elena J, Yi, Lan, Davis, Jaclyn, Masood, Aisha, Flinn, Ian W., Dickinson, Michael

Volltext